ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02038673
Brief Title: An Open-label Phase I Study of Orally Available Novel Small-molecule Fibroblast Growth Factor Receptors (FGFR) 1,2,3 and 4 Inhibitor, ASP5878 at Single and Multiple Doses in Patients With Solid Tumors

First Submitted : January 15, 2014
First Submitted that Met QC Criteria : January 15, 2014
First Posted : January 16, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : July 17, 2018
Last Update Posted : July 19, 2018